Chronic heart failure in Japan: implications of the CHART studies

Nobuyuki Shiba1, Hiroaki Shimokawa

  • 1Department of Cardiovascular Medicine, Department of Evidence-Based Cardiovascular Medicine, Tohoku University Graduate School of Medicine Sendai City, Japan. nshiba@cardio.med.tohoku.ac.jp

Insights

Chronic heart failure (CHF) prognosis remains poor, even with advanced treatments. Japanese CHF patients face similar poor outcomes as Western populations, highlighting the need for more research and prevention strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Chronic heart failure (CHF) poses a significant public health challenge, particularly in aging industrialized nations.
  • While historically lower in Japan, CHF prevalence and mortality are increasing due to societal aging and lifestyle changes.
  • Despite medical advances, the prognosis for CHF patients remains poor.

Purpose of the Study:

  • To review the current status of chronic heart failure (CHF) research in Japan.
  • To discuss the findings of the Chronic Heart Failure Analysis and Registry in the Tohoku District (CHART)-1 study.
  • To highlight the need for further evidence and the initiation of the CHART-2 study for CHF prevention in Japan.

Main Methods:

  • Analysis of data from the CHART-1 study, one of Japan's largest CHF cohorts.
  • Review of existing literature on CHF prevalence, characteristics, and prognosis in Japan.
  • Description of the objectives and design of the prospective CHART-2 study.

Main Results:

  • The CHART-1 study revealed that Japanese CHF patients have a prognosis comparable to Western populations.
  • The study identified key characteristics of CHF in the Japanese population.
  • Evidence suggests a growing need for prevention strategies alongside treatment.

Conclusions:

  • Japanese patients with chronic heart failure (CHF) experience poor prognoses similar to those in Western countries.
  • There is a critical need for large-scale cohort studies and randomized trials in Japan to inform prevention and treatment strategies.
  • The ongoing CHART-2 study aims to identify risk factors for CHF in Japan, shifting focus towards prevention.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...